Skip to Content
주식/증권 📈 긍정적

Reasons to Retain Doximity Stock in Your Portfolio for Now

요약

DOCS is ramping up AI across physician workflows and enterprise tools, but weak pharma ads and higher AI spending may test near-term growth.